Pulmonary

The transition to electric cars and renewable energy sources has the potential to significantly improve children’s health. As the world...

The global propellants market is projected to experience significant growth in the coming years, with a compound annual growth rate...

FDA Endorses Tricuspid Regurgitation Device Following Positive Findings in TRILUMINATE Clinical Trial Tricuspid regurgitation (TR) is a condition where the...

A Comprehensive Guide to Choosing the Best Nebulizer in India Nebulizers are medical devices that are used to deliver medication...

An Overview of Wearable Respiratory Sensors for Health Monitoring in NPG Asia Materials In recent years, there has been a...

Phase I Thromboembolic Disorder Trial Commences Subject Dosing by Sirius Sirius Pharmaceuticals, a leading biopharmaceutical company, has announced the commencement...

Medical Device News Magazine Highlights CT Scan as the Optimal Method for Evaluating Individuals with Chest Pain Chest pain is...

Thirona’s LungQ V3.0.0 Software Granted FDA 510(k) Clearance for AI Analysis of Chest CT Images, Reports Medical Device News Magazine...

The role of S100A8/A9 in promoting endometrial fibrosis through the regulation of RAGE/JAK2/STAT3 signaling pathway – Insights from Communications Biology...

Title: FDA Warnings, Bryan Johnson’s NYT Feature, and MUSE Cell Trial: Key Developments in the Biotech Industry Introduction: The biotech...

Title: Improvements in American Air Quality, Yet Unequal Distribution of Benefits Introduction: Air pollution is a significant environmental issue that...

The Connection Between Smoking Marijuana and Cigarettes and Increased Lung Damage: Insights from the Medical Marijuana Program In recent years,...

Metagenomi and ArriVent Submit IPO Filings: Jan. 5 Quick Takes On January 5, 2022, two biotechnology companies, Metagenomi and ArriVent,...

C4X Discovery, a leading drug discovery company, is making significant strides in advancing drug discovery through its NRF2 Activator Program....

Alfasigma SpA, an Italian pharmaceutical company, and Galapagos NV, a Belgian biotechnology company, have recently announced a significant collaboration agreement...